Balance sheet of Gland Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Gland Pharma is decreasing.
Latest net debt of Gland Pharma is -₹4,843.19 Crs as of Mar-25.
This is less than Mar-24 when it was -₹3,359.07 Crs.

No, profit is decreasing.
The profit of Gland Pharma is ₹699 Crs for Mar 2025, ₹772 Crs for Mar 2024 and ₹781 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Gland Pharma latest dividend payout ratio is 42.46% and 3yr average dividend payout ratio is 42.55%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances